512 related articles for article (PubMed ID: 12856215)
21. Combination therapeutic approaches for the management of invasive aspergillosis in organ transplant recipients.
Singh N; Pursell KJ
Mycoses; 2008 Mar; 51(2):99-108. PubMed ID: 18254745
[TBL] [Abstract][Full Text] [Related]
22. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome.
Singh N; Aguado JM; Bonatti H; Forrest G; Gupta KL; Safdar N; John GT; Pursell KJ; Muñoz P; Patel R; Fortun J; Martin-Davila P; Philippe B; Philit F; Tabah A; Terzi N; Chatelet V; Kusne S; Clark N; Blumberg E; Julia MB; Humar A; Houston S; Lass-Flörl C; Johnson L; Dubberke ER; Barron MA; Lortholary O
J Infect Dis; 2009 Sep; 200(6):1002-11. PubMed ID: 19659439
[TBL] [Abstract][Full Text] [Related]
23. Antifungal prophylaxis in lung transplantation.
Avery RK
Semin Respir Crit Care Med; 2011 Dec; 32(6):717-26. PubMed ID: 22167399
[TBL] [Abstract][Full Text] [Related]
24. Phaeohyphomycosis in a tertiary care cancer center.
Ben-Ami R; Lewis RE; Raad II; Kontoyiannis DP
Clin Infect Dis; 2009 Apr; 48(8):1033-41. PubMed ID: 19267655
[TBL] [Abstract][Full Text] [Related]
25. Scedosporium apiospermum: an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes.
Shinohara MM; George E
J Cutan Pathol; 2009 Oct; 36 Suppl 1():39-41. PubMed ID: 19775393
[TBL] [Abstract][Full Text] [Related]
26. Fungi and molds following lung transplantation.
Hosseini-Moghaddam SM; Husain S
Semin Respir Crit Care Med; 2010 Apr; 31(2):222-33. PubMed ID: 20354934
[TBL] [Abstract][Full Text] [Related]
27. Itraconazole: managing mycotic complications in immunocompromised patients.
Graybill JR
Semin Oncol; 1998 Jun; 25(3 Suppl 7):58-63. PubMed ID: 9671333
[TBL] [Abstract][Full Text] [Related]
28. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients.
Singh N; Avery RK; Munoz P; Pruett TL; Alexander B; Jacobs R; Tollemar JG; Dominguez EA; Yu CM; Paterson DL; Husain S; Kusne S; Linden P
Clin Infect Dis; 2003 Jan; 36(1):46-52. PubMed ID: 12491201
[TBL] [Abstract][Full Text] [Related]
29. Trends in invasive disease due to Candida species following heart and lung transplantation.
Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
[TBL] [Abstract][Full Text] [Related]
30. Fungal infections after lung transplantation.
Solé A; Salavert M
Transplant Rev (Orlando); 2008 Apr; 22(2):89-104. PubMed ID: 18631862
[TBL] [Abstract][Full Text] [Related]
31. [Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update].
Fortún J; Carratalá J; Gavaldá J; Lizasoain M; Salavert M; de la Cámara R; Borges M; Cervera C; Garnacho J; Lassaleta Á; Lumbreras C; Sanz MÁ; Ramos JT; Torre-Cisneros J; Aguado JM; Cuenca-Estrella M;
Enferm Infecc Microbiol Clin; 2011; 29(6):435-54. PubMed ID: 21474210
[TBL] [Abstract][Full Text] [Related]
32. Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.
Pinney MF; Rosenberg AF; Hampp C; Schain D; Akindipe O; Baz M
Pharmacotherapy; 2011 Jun; 31(6):537-45. PubMed ID: 21923437
[TBL] [Abstract][Full Text] [Related]
33. Aspergillus infections in lung transplant recipients: risk factors and outcome.
Solé A; Morant P; Salavert M; Pemán J; Morales P;
Clin Microbiol Infect; 2005 May; 11(5):359-65. PubMed ID: 15819861
[TBL] [Abstract][Full Text] [Related]
34. Invasive aspergillosis in solid-organ transplantation: report of eight cases and review of the literature.
Ergin F; Arslan H; Azap A; Demirhan B; Karakayali H; Haberal M
Transpl Int; 2003 Apr; 16(4):280-6. PubMed ID: 12730810
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients.
Grossi P; Farina C; Fiocchi R; Dalla Gasperina D
Transplantation; 2000 Jul; 70(1):112-6. PubMed ID: 10919584
[TBL] [Abstract][Full Text] [Related]
36. Fungal infections in solid organ transplant recipients.
Hadley S; Karchmer AW
Infect Dis Clin North Am; 1995 Dec; 9(4):1045-74. PubMed ID: 8747778
[TBL] [Abstract][Full Text] [Related]
37. Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature.
Salmon A; Debourgogne A; Vasbien M; Clément L; Collomb J; Plénat F; Bordigoni P; Machouart M
Clin Microbiol Infect; 2010 May; 16(5):508-12. PubMed ID: 19624505
[TBL] [Abstract][Full Text] [Related]
38. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Baden LR; Katz JT; Fishman JA; Koziol C; DelVecchio A; Doran M; Rubin RH
Transplantation; 2003 Dec; 76(11):1632-7. PubMed ID: 14702539
[TBL] [Abstract][Full Text] [Related]
39. Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used?
Muñoz P; Singh N; Bouza E
Curr Opin Infect Dis; 2006 Aug; 19(4):365-70. PubMed ID: 16804385
[TBL] [Abstract][Full Text] [Related]
40. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
Salavert M
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
